O’Leary et al., 2003 - Google Patents
Metabolism of quercetin-7-and quercetin-3-glucuronides by an in vitro hepatic model: the role of human β-glucuronidase, sulfotransferase, catechol-O …O’Leary et al., 2003
- Document ID
- 9190934162384903332
- Author
- O’Leary K
- Day A
- Needs P
- Mellon F
- O’Brien N
- Williamson G
- Publication year
- Publication venue
- Biochemical pharmacology
External Links
Snippet
Quercetin-3-and quercetin-7-glucuronides are major products of small intestine epithelial cell metabolism (J. Nutr. 130 (2000) 2765) but it is not known if quercetin glucuronides can be further processed in the liver or if they are excreted directly. Using the HepG2 hepatic cell …
- 230000036740 Metabolism 0 title abstract description 53
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| O’Leary et al. | Metabolism of quercetin-7-and quercetin-3-glucuronides by an in vitro hepatic model: the role of human β-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism | |
| O’Leary et al. | Flavonoid glucuronides are substrates for human liver β-glucuronidase | |
| Day et al. | Conjugation position of quercetin glucuronides and effect on biological activity | |
| Galijatovic et al. | Extensive metabolism of the flavonoid chrysin by human Caco-2 and Hep G2 cells | |
| Reen et al. | Impairment of UDP-glucose dehydrogenase and glucuronidation activities in liver and small intestine of rat and guinea pig in vitro by piperine | |
| Day et al. | Biomarkers for exposure to dietary flavonoids: a review of the current evidence for identification of quercetin glycosides in plasma | |
| Crespy et al. | Comparison of the intestinal absorption of quercetin, phloretin and their glucosides in rats | |
| Choudhury et al. | Urinary excretion of hydroxycinnamates and flavonoids after oral and intravenous administration | |
| Bort et al. | Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity | |
| Kwon et al. | Comparison of oral bioavailability of genistein and genistin in rats | |
| Day et al. | Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β-glucosidase activity | |
| Zhang et al. | Mechanistic study on the intestinal absorption and disposition of baicalein | |
| Breinholt et al. | Estrogenic activity of flavonoids in mice. The importance of estrogen receptor distribution, metabolism and bioavailability | |
| Lash et al. | Cytotoxicity of S-(1, 2-dichlorovinyl) glutathione and S-(1, 2-dichlorovinyl)-L-cysteine in isolated rat kidney cells. | |
| Day et al. | Absorption of quercetin-3-glucoside and quercetin-4′-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter | |
| Graf et al. | Rat gastrointestinal tissues metabolize quercetin | |
| Wang et al. | Disposition of flavonoids via enteric recycling: structural effects and lack of correlations between in vitro and in situ metabolic properties | |
| Zhu et al. | Breast cancer resistance protein (BCRP) and sulfotransferases contribute significantly to the disposition of genistein in mouse intestine | |
| Nakano et al. | Regioselective monosulfation and disulfation of the phytoestrogens daidzein and genistein by human liver sulfotransferases | |
| Totta et al. | Daidzein-sulfate metabolites affect transcriptional and antiproliferative activities of estrogen receptor-β in cultured human cancer cells | |
| Alhusainy et al. | Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect | |
| Hu et al. | Metabolism of calycosin, an isoflavone from Astragali Radix, in zebrafish larvae | |
| Barrington et al. | MK571 inhibits phase-2 conjugation of flavonols by Caco-2/TC7 cells, but does not specifically inhibit their apical efflux | |
| Perrier et al. | In vitro N-glucuronidation of SB 47436 (BMS 186295), a new AT1 nonpeptide angiotensin II receptor antagonist, by rat, monkey and human hepatic microsomal fractions. | |
| Dawson et al. | Xenobiotic metabolism by isolated intestinal epithelial cells from guinea-pigs |